Comparison of Radiographic Progression-Free Survival and PSA Response on Sequential Treatment Using Abiraterone and Enzalutamide for Newly Diagnosed Castration-Resistant Prostate Cancer: A Propensity Score Matched Analysis from Multicenter Cohort

Background: There is emerging evidence that radiographic progression-free survival (rPFS) is highly correlated with overall survival (OS), potentially serving as an indicator of treatment outcome for castration-resistant prostate cancer (CRPC). The objective of this study is to assess rPFS and prost...

Descripción completa

Detalles Bibliográficos
Autores principales: Komura, Kazumasa, Fujiwara, Yuya, Uchimoto, Taizo, Saito, Kenkichi, Tanda, Naoki, Matsunaga, Tomohisa, Ichihashi, Atsushi, Tsutsumi, Takeshi, Tsujino, Takuya, Yoshikawa, Yuki, Nishimoto, Yudai, Takai, Tomoaki, Minami, Koichiro, Taniguchi, Kohei, Tanaka, Tomohito, Uehara, Hirofumi, Hirano, Hajime, Nomi, Hayahito, Ibuki, Naokazu, Takahara, Kiyoshi, Inamoto, Teruo, Azuma, Haruhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723570/
https://www.ncbi.nlm.nih.gov/pubmed/31430900
http://dx.doi.org/10.3390/jcm8081251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723570/
https://www.ncbi.nlm.nih.gov/pubmed/31430900
http://dx.doi.org/10.3390/jcm8081251

Ejemplares similares